These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. Moroz G; Rosenbaum JF J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979 [TBL] [Abstract][Full Text] [Related]
7. Carbon dioxide/oxygen challenge test in panic disorder. Perna G; Battaglia M; Garberi A; Arancio C; Bertani A; Bellodi L Psychiatry Res; 1994 May; 52(2):159-71. PubMed ID: 7972572 [TBL] [Abstract][Full Text] [Related]
8. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. Rosenbaum JF; Moroz G; Bowden CL J Clin Psychopharmacol; 1997 Oct; 17(5):390-400. PubMed ID: 9315990 [TBL] [Abstract][Full Text] [Related]
9. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Pols H; Verburg K; Hauzer R; Meijer J; Griez E Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779 [TBL] [Abstract][Full Text] [Related]
10. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451 [TBL] [Abstract][Full Text] [Related]
11. Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder. Beckett A; Fishman SM; Rosenbaum JF J Clin Psychiatry; 1986 Sep; 47(9):475-6. PubMed ID: 3091584 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of carbon dioxide-induced panic after clonazepam treatment. Pols H; Zandbergen J; de Loof C; Griez E Acta Psychiatr Scand; 1991 Dec; 84(6):585-6. PubMed ID: 1792935 [TBL] [Abstract][Full Text] [Related]
14. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132 [TBL] [Abstract][Full Text] [Related]
15. Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Griez E; de Loof C; Pols H; Zandbergen J; Lousberg H Psychiatry Res; 1990 Feb; 31(2):193-9. PubMed ID: 2109330 [TBL] [Abstract][Full Text] [Related]
16. Alprazolam blockade of CO2-provoked panic in patients with panic disorder. Sanderson WC; Wetzler S; Asnis GM Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic response to benzodiazepine in panic disorder subtypes. Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055 [TBL] [Abstract][Full Text] [Related]
18. Early coadministration of clonazepam with sertraline for panic disorder. Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study. Perna G; Cocchi S; Bertani A; Arancio C; Bellodi L J Clin Psychopharmacol; 1994 Dec; 14(6):414-8. PubMed ID: 7884022 [TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity to inhalation of carbon dioxide and panic attacks. Perna G; Gabriele A; Caldirola D; Bellodi L Psychiatry Res; 1995 Aug; 57(3):267-73. PubMed ID: 7501737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]